Valziflocept (BAX1810, TAK-752) is a recombinant soluble human FcgammaRIIb receptor that targets Fc and FcgammaR. FcgammaRs bind and neutralize pathogenic IgG, thus forming a decoy or scavenger receptor that can reduce the severity of autoimmune diseases. Valziflocept can be used in studies of autoimmune diseases such as systemic lupus erythematosus (SLE)[1].
Molekulargewicht:
(19.693 kDa)
Reinheit:
99.00
CAS Nummer:
[1804910-11-9]
Target-Kategorie:
Fc Receptor (FcR)
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten